Inovio Poised For Breakthroughs In 2018 And Beyond
NASDAQ,
By Douglas McBride : Discussion Many investors that look at Inovio see a 2020 market opportunity for Inovio's flagship product (V…
By Douglas McBride : Discussion Many investors that look at Inovio see a 2020 market opportunity for Inovio's flagship product (V…
Discussion Many investors that look at Inovio see a 2020 market opportunity for Inovio’s flagship product (VGX-3100) for…
Aug. 17 (UPI) — Researchers at The Wistar Institute have created a new immunotherapy technology to treat prostate cancer using…
Aug. 17 (UPI) -- Researchers at The Wistar Institute have created a new immunotherapy technology to treat prostate cancer using…
Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia A study led by…
Return to Article List This gene-based delivery system can instruct the body to generate therapeutic antibodies against cancer…
PHILADELPHIA -- (Aug. 17, 2017) -- A study led by scientists at The Wistar Institute describes a novel immunotherapeutic…